X
X
Total 393357 Results
| Label | Description | ILX | Version | Created CID | Modified Time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Muellerian hormone type-2 receptor | A protein that is a translation product of the AMHR2 gene or a 1:1 ortholog thereof. (PRO:CNA) | ILX:0100788 | 7 | scicrunch | 10/24/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Antibody | An antibody is any of the structurally related proteins that function as immunoglobulins. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity. | ILX:0100789 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antibody supplier | A material resource provider, such as a vendor or noncommercial entity, that provides access to antibodies. | ILX:0100790 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Anticonvulsant drug | ILX:0100791 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Antidepressant drug | A mood-stimulating drug used primarily in the treatment of affective disorders and related conditions. | ILX:0100792 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antihemophilic Factor | Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells Pharmacology: Antihemophilic Factor binds factor IXa along with calcium and phospholipid, This complex converts factor X to factor Xa to facilitate clotting cascade. Mechanism of action: Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia). Drug type: Approved. Biotech. Investigational. Drug category: Coagulants. Thrombotic Agents | ILX:0100793 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antioxidant | A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. | ILX:0100794 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antipsychotic drug | are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. | ILX:0100795 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antisaccade-prosaccade task | Subjects view a fixation point and a visual target is presented. Subjects are instructed to make a saccade away from the target (antisaccade) or to the target (prosaccade). | ILX:0100796 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antithymocyte globulin | Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells. Pharmacology: This immunosuppressive product, obtained by immunization of rabbits with human thymocytes, contains cytotoxic antibodies directed against antigens expressed on human T-lymphocytes. This reduces the host immune response against tissue transplants or organ allografts. Mechanism of action: Binds to multiple, T-cell specific antigens leading to T-lymphocyte cell death via complement mediated cytotoxicity or apoptosis. Drug type: Approved. Biotech. Drug category: Immunomodulatory Agents | ILX:0100797 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Antrozous | ILX:0100798 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Anucleate | A nucleate quality inhering a bearer by virtue of having no nucleus. | ILX:0100799 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Anura | ILX:0100800 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Anxiety Disorder | Persistent and disabling ANXIETY (MeSH). | ILX:0100801 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Anxiety Status Inventory | The ASI is an assessment of anxiety, consists of 20 somatic and affective symptoms of anxiety. Each item is rated on severity from 1 to 4, where 1 indicates none and 4 indicates severe. The raw score range is from 20 - 80. This is converted to a percentage, by dividing the raw score by 80 and multiplying by 100. Low scores or percentages indicate low levels of anxiety and high scores indicate high levels of anxiety. | ILX:0100802 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Aotidae | ILX:0100803 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Aotus | ILX:0100804 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Aotus azarai | ILX:0100805 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Aotus trivirgatus | ILX:0100806 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Apache License | A free software license authored by the Apache Software Foundation (ASF) which requires preservation of the copyright notice and disclaimer, but is not a copyleft license. It allows use of the source code for the development of proprietary software in addition to free, open source software. (From http://en.wikipedia.org/wiki/Apache_License)http://www.apache.org/licenses/LICENSE-2.0.html | ILX:0100807 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
About
Base community for the SciCrunch.org infrastructure
Contact Us
X